1. Home
  2. HAE vs JBTM Comparison

HAE vs JBTM Comparison

Compare HAE & JBTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

SELL

Current Price

$121.39

Market Cap

5.4B

Sector

Health Care

ML Signal

SELL

Logo JBT Marel Corporation

JBTM

JBT Marel Corporation

SELL

Current Price

$124.93

Market Cap

5.6B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
HAE
JBTM
Founded
1971
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.6B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
HAE
JBTM
Price
$121.39
$124.93
Analyst Decision
Buy
Buy
Analyst Count
12
9
Target Price
$147.18
★ $160.13
AVG Volume (30 Days)
★ 591.2K
482.1K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
★ 0.32%
EPS Growth
★ N/A
N/A
EPS
1.72
★ 2.73
Revenue
$910,373,000.00
★ $3,798,200,000.00
Revenue This Year
$8.17
$4.56
Revenue Next Year
$10.82
$4.99
P/E Ratio
$71.52
★ $45.93
Revenue Growth
N/A
★ 121.34
52 Week Low
$51.00
$102.97
52 Week High
$132.00
$170.19

Technical Indicators

Market Signals
Indicator
HAE
JBTM
Relative Strength Index (RSI) 55.70 65.96
Support Level $115.49 $121.39
Resistance Level $122.84 $137.11
Average True Range (ATR) 4.60 4.39
MACD -0.42 0.84
Stochastic Oscillator 31.72 75.75

Price Performance

Historical Comparison
HAE
JBTM

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

About JBTM JBT Marel Corporation

JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.

Share on Social Networks: